Peripheral effects of opioids in a model of chronic intestinal inflammation in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 3, 1998, Pages 1068-1075

  Puig, Margarita M ^a   Pol, Olga ^a  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; BETA FUNALTREXAMINE; CROTON OIL; ENKEPHALIN; FENTANYL; LOPERAMIDE; MORPHINE; MU OPIATE RECEPTOR; OPIATE; ANTIDIARRHEAL AGENT; BETA-FUNALTREXAMINE; CARBON MONOXIDE; DRUG DERIVATIVE; NALTREXONE; NARCOTIC AGENT; NARCOTIC ANTAGONIST; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENCY; ENTERITIS; GASTROINTESTINAL TRANSIT; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; WEIGHT REDUCTION; ANIMAL; BIOSYNTHESIS; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; JEJUNUM; MALE; PATHOLOGY; PATHOPHYSIOLOGY; ULTRASTRUCTURE;

ANIMALS; ANTIDIARRHEALS; BODY WEIGHT; CARBON MONOXIDE; ENTERITIS; GASTROINTESTINAL TRANSIT; JEJUNUM; LOPERAMIDE; MALE; MICE; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; RECEPTORS, OPIOID;

EID: 0032253103     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Antonijevic I, Mousa SA, Schäfer M and Stein C (1995) Perineural defect and peripheral opioid analgesia in inflammation. J Neurosci 15:165-172.
2. Awouters F, Megens A, Verlinden M, Schuurkes J, Niemegeers C and Janssen PAJ (1993) Loperamide. Survey of studies on mechanism of its antidiarrheal activity. Dig Dis Sei 38:977-995.
3. Chen C, Xue JC, Zhu J, Chen YW, Kunapuli S, De Kiel JK, Yu L and Chen LYL (1995) Characterization of irreversible binding of β-funaltrexamine to the cloned rat IL opioid receptor. J Biol Chem 270:17866-17870.
4. Furchgott R and Bursztyn P (1967) Comparison of dissociation constants and of relative efficacies of selected agonists acting on parasympathetic receptors. Ann NYAcadSci 144:882-899.
5. Hassan AHS, Ableitner A, Stein C and Herz A (1993) Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience 55:185-195.
6. Hurwitz A, Sztern MI, Looney GA and Ben-Zvi Z (1994) Loperamide effects on hepatobiliary function, intestinal transit and analgesia in mice. Life Sei 54:1687-1698.
7. Jiang QL, Heyman JS, Sheldon RJ, Koslo RJ and Porreca F (1990) Mu antagonist and kappa agonist properties of β-funaltrexamine (β-FNA) in vivo: Long-lasting spinal analgesia in mice. J Pharmacol Exp Ther 252:1006-1011.
8. Magnam J, Paterson SJ, Tavani A and Kosterlitz HW (1982) The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties. Nau-nyn-Schmiedeberg's Arch Pharmacol 319:197-205.
9. Mjanger E and Yaksh TL (1991) Characteristics of dose-dependent antagonism by β-funaltrexamine of the antinociceptive effects of intrathecal agonists. J Pharmacol Exp Ther 258:544-549.
10. Palmer MJ, Dieleman LA, Van Der Ende MB, Uyterlinde A, Pena AS, Meuwissen SG and Van Rees EP (1995) Non-lymphoid and lymphoid cells in acute, chronic and relapsing experimental colitis. Clin Exp Immunol 99:226-232.
11. Pol 0, Ferrer I and Puig MM (1994) Diarrhea associated with intestinal inflammation increases the potency of n and 8 opioids on the inhibition of gastrointestinal transit in mice. J Pharmacol Exp Ther 270:386-391.
12. Pol 0, Planas E and Puig MM (1995) Peripheral effects of naloxone in mice with acute diarrhea associated with intestinal inflammation. J Pharmacol Exp Ther 272:1271-1276.
13. Pol O, Valle LI, Ferrer I and Puig MM (1996) The inhibitory effects of t2- adrenoceptors agonists on gastrointestinal transit during croton oil-induced intes-tinal inflammation. Br J Pharmacol 119:1649-1655.
14. Pol O and Puig MM (1997) Reversal of tolerance to the antitransit effects of morphine during acute intestinal inflammation in mice. Br J Pharmacol 122:1216-1222.
15. Portoghese PS, Sultana M and Takemori AE (1988) Naltrindole, a highly selective and potent, non-peptide delta opioid receptor antagonist. Eur J Pharmacol 146: 185-186.
16. Puig MM, Pol 0 and Warner W (1996) Interaction of morphine and clonidine on gastrointestinal transit in mice. Anesthesiology 86:1403-1412.
17. Schäfer M, Imai Y, Uni GR and Stein C (1995) Inflammation enhances peripheral jii-opioid analgesia, but not i-opioid receptor transcription in dorsal root ganglia. Eur J Pharmacol 279:165-169.
18. Selley DE, Breivogel CS and Childers SR (1993) Modification of opioid receptor-G- protein function by low pH pretreatment of membranes from NG108-15 cells: Increase in opioid agonist efficacy by decreased inactivation of G-proteins. Mol Pharmacol 44:731-741.
19. Shook JE, Lemcke PK, Gehrig CA, Hruby VJ and Burks TF (1989) Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: Inhibition of diarrhea without constipation. J Pharmacol Exp Ther 249:83-90.
20. Shook JE, Pelton JT, Hruby VJ and Burks TF (1987) Peptide opioid antagonists separate peripheral and central opioid antitransit effects. J Pharmacol Exp Ther 243:492-500.
21. Stein C (1995) The control of pain in peripheral tissue by opioids. N E J Med 332:1685-1690.
22. Stein C, Millian MJ, Shippenbers TS, Peter K and Herz A (1989) Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. J Pharmacol Exp Ther 248:1269-1275.
23. Tallarida RJ and Murray RB (1986) Manual of Pharmacologie Calculations with Computer Programs. Springer-Verlag, New York.
24. Ward SJ, Portoghese PS and Takemori AE (1982) Pharmacological characterization in vivo of the novel opiate, β-funaltrexamine. J Pharmacol Exp Ther 220:494-498.
25. Zhang 0, Schäfer M and Stein C (1996) Effect of capsaicin on the expression of cloned opioid receptors in dorsal root ganglia. Book of Abstracts, Soc Neurosci 22:2004.